Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NUVB |
---|---|---|
09:34 ET | 600 | 3.36 |
09:38 ET | 3800 | 3.375 |
09:39 ET | 600 | 3.36 |
09:41 ET | 15661 | 3.38 |
09:43 ET | 3100 | 3.38 |
09:45 ET | 200 | 3.395 |
09:48 ET | 600 | 3.42 |
09:50 ET | 3363 | 3.425 |
09:52 ET | 900 | 3.435 |
09:54 ET | 2611 | 3.45 |
09:56 ET | 425 | 3.446 |
09:57 ET | 200 | 3.45 |
09:59 ET | 2390 | 3.435 |
10:01 ET | 1253 | 3.45 |
10:03 ET | 8064 | 3.455 |
10:06 ET | 1826 | 3.455 |
10:08 ET | 6978 | 3.435 |
10:10 ET | 3164 | 3.418 |
10:12 ET | 1177 | 3.425 |
10:14 ET | 2131 | 3.431 |
10:15 ET | 200 | 3.44 |
10:17 ET | 5128 | 3.415 |
10:19 ET | 700 | 3.425 |
10:21 ET | 1311 | 3.425 |
10:24 ET | 796 | 3.44 |
10:26 ET | 500 | 3.445 |
10:28 ET | 14489 | 3.39 |
10:30 ET | 62044 | 3.375 |
10:32 ET | 2116 | 3.381 |
10:33 ET | 427 | 3.385 |
10:35 ET | 300 | 3.39 |
10:37 ET | 150 | 3.3861 |
10:39 ET | 700 | 3.39 |
10:42 ET | 1390 | 3.385 |
10:44 ET | 1285 | 3.39 |
10:46 ET | 25754 | 3.365 |
10:48 ET | 1004 | 3.3612 |
10:50 ET | 2327 | 3.365 |
10:51 ET | 900 | 3.365 |
10:53 ET | 100 | 3.37 |
10:55 ET | 600 | 3.37 |
10:57 ET | 4974 | 3.365 |
11:00 ET | 500 | 3.365 |
11:02 ET | 1682 | 3.36 |
11:04 ET | 1500 | 3.355 |
11:06 ET | 1400 | 3.355 |
11:08 ET | 4166 | 3.3675 |
11:09 ET | 1049 | 3.365 |
11:11 ET | 700 | 3.365 |
11:13 ET | 700 | 3.37 |
11:15 ET | 4291 | 3.355 |
11:18 ET | 700 | 3.355 |
11:20 ET | 300 | 3.355 |
11:22 ET | 1570 | 3.355 |
11:24 ET | 943 | 3.355 |
11:26 ET | 10032 | 3.355 |
11:27 ET | 1830 | 3.345 |
11:29 ET | 700 | 3.345 |
11:31 ET | 1293 | 3.345 |
11:33 ET | 3098 | 3.335 |
11:36 ET | 700 | 3.34 |
11:38 ET | 300 | 3.34 |
11:40 ET | 200 | 3.335 |
11:42 ET | 325 | 3.335 |
11:44 ET | 443 | 3.335 |
11:45 ET | 700 | 3.335 |
11:47 ET | 994 | 3.335 |
11:49 ET | 3496 | 3.325 |
11:51 ET | 2676 | 3.345 |
11:56 ET | 397 | 3.345 |
11:58 ET | 200 | 3.35 |
12:00 ET | 100 | 3.35 |
12:02 ET | 3949 | 3.355 |
12:03 ET | 861 | 3.355 |
12:05 ET | 858 | 3.355 |
12:07 ET | 758 | 3.355 |
12:09 ET | 9717 | 3.375 |
12:12 ET | 300 | 3.38 |
12:14 ET | 1505 | 3.375 |
12:16 ET | 200 | 3.375 |
12:18 ET | 400 | 3.375 |
12:20 ET | 100 | 3.375 |
12:21 ET | 4764 | 3.39 |
12:25 ET | 400 | 3.39 |
12:27 ET | 300 | 3.39 |
12:30 ET | 300 | 3.39 |
12:32 ET | 1678 | 3.39 |
12:34 ET | 400 | 3.39 |
12:36 ET | 3238 | 3.4 |
12:38 ET | 200 | 3.4 |
12:39 ET | 1924 | 3.4 |
12:41 ET | 400 | 3.4 |
12:43 ET | 5556 | 3.39 |
12:45 ET | 4024 | 3.375 |
12:48 ET | 1400 | 3.38 |
12:52 ET | 1722 | 3.39 |
12:54 ET | 100 | 3.4 |
12:56 ET | 8951 | 3.3826 |
12:59 ET | 100 | 3.385 |
01:01 ET | 100 | 3.39 |
01:06 ET | 7125 | 3.37 |
01:08 ET | 100 | 3.37 |
01:10 ET | 3298 | 3.375 |
01:12 ET | 100 | 3.38 |
01:15 ET | 400 | 3.375 |
01:17 ET | 250 | 3.3791 |
01:19 ET | 300 | 3.375 |
01:21 ET | 200 | 3.375 |
01:24 ET | 804 | 3.375 |
01:26 ET | 6514 | 3.39 |
01:28 ET | 200 | 3.39 |
01:30 ET | 100 | 3.39 |
01:32 ET | 3612 | 3.4 |
01:33 ET | 7431 | 3.385 |
01:35 ET | 2149 | 3.385 |
01:37 ET | 6625 | 3.385 |
01:39 ET | 2064 | 3.385 |
01:42 ET | 900 | 3.385 |
01:44 ET | 100 | 3.39 |
01:46 ET | 100 | 3.385 |
01:48 ET | 1498 | 3.385 |
01:50 ET | 12371 | 3.37 |
01:53 ET | 2240 | 3.365 |
01:55 ET | 100 | 3.365 |
01:57 ET | 300 | 3.365 |
02:00 ET | 200 | 3.365 |
02:02 ET | 400 | 3.365 |
02:04 ET | 6839 | 3.345 |
02:08 ET | 100 | 3.34 |
02:09 ET | 10952 | 3.355 |
02:13 ET | 16024 | 3.355 |
02:15 ET | 2206 | 3.34 |
02:20 ET | 2132 | 3.3385 |
02:22 ET | 2251 | 3.325 |
02:24 ET | 1500 | 3.315 |
02:26 ET | 300 | 3.32 |
02:27 ET | 400 | 3.315 |
02:29 ET | 300 | 3.315 |
02:31 ET | 600 | 3.315 |
02:33 ET | 4734 | 3.3009 |
02:36 ET | 100 | 3.3 |
02:38 ET | 3258 | 3.29 |
02:40 ET | 600 | 3.29 |
02:42 ET | 5485 | 3.305 |
02:44 ET | 200 | 3.3 |
02:45 ET | 9038 | 3.305 |
02:49 ET | 200 | 3.31 |
02:51 ET | 1538 | 3.305 |
02:54 ET | 600 | 3.305 |
02:56 ET | 400 | 3.305 |
02:58 ET | 6991 | 3.31 |
03:00 ET | 4600 | 3.305 |
03:02 ET | 5853 | 3.31 |
03:03 ET | 600 | 3.3 |
03:05 ET | 10615 | 3.295 |
03:07 ET | 300 | 3.29 |
03:09 ET | 1118 | 3.29 |
03:12 ET | 9462 | 3.295 |
03:14 ET | 2671 | 3.29 |
03:16 ET | 600 | 3.29 |
03:18 ET | 471 | 3.295 |
03:20 ET | 300 | 3.29 |
03:21 ET | 1208 | 3.295 |
03:23 ET | 1710 | 3.295 |
03:25 ET | 700 | 3.295 |
03:27 ET | 1525 | 3.3 |
03:30 ET | 1601 | 3.295 |
03:32 ET | 1800 | 3.295 |
03:34 ET | 14317 | 3.31 |
03:36 ET | 1100 | 3.31 |
03:38 ET | 1810 | 3.305 |
03:39 ET | 1600 | 3.31 |
03:41 ET | 2450 | 3.31 |
03:43 ET | 2421 | 3.31 |
03:45 ET | 10732 | 3.295 |
03:48 ET | 1182 | 3.295 |
03:50 ET | 2500 | 3.29 |
03:52 ET | 12169 | 3.31 |
03:54 ET | 11391 | 3.32 |
03:56 ET | 9884 | 3.32 |
03:57 ET | 22993 | 3.31 |
03:59 ET | 36754 | 3.32 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nuvation Bio Inc | 820.6M | -10.6x | --- |
Longboard Pharmaceuticals Inc | 804.4M | -9.2x | --- |
CARGO Therapeutics Inc | 803.9M | -8.6x | --- |
Disc Medicine Inc | 795.5M | -9.5x | --- |
89Bio Inc | 849.1M | -4.3x | --- |
Prime Medicine Inc | 849.8M | -3.3x | --- |
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $820.6M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 247.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.44 |
EPS | $-0.31 |
Book Value | $2.76 |
P/E Ratio | -10.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.